Connecting the Dots: Mitochondrial Dysfunction, PCOS, and Insulin Resistance—Insights and Therapeutic Advances
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136233 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Samia Palat Tharayil und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Endocrinology, The Indian Council of Medical Research-National Institute for Research in Reproductive and Child Health (ICMR-…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Insulin Resistance, Mitochondria. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 214 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research (ICMR), ICMR-National Institute for Research in Reproductive and Child Health (NIRRCH).
Abstract (Originalsprache)
Insulin resistance (IR) frequently develops in women with polycystic ovary syndrome (PCOS), an endocrinological disorder typified by hyperandrogenaemia, erratic menstrual cycles, and the presence of multiple cysts in the ovaries. It results in elevated androgen production contributing to the clinical manifestations of the syndrome including associated co-morbidities such as obesity and type 2 diabetes (T2D). Mounting data suggest the involvement of free fatty acids, reactive oxygen species (ROS) signalling, and mitochondrial dysfunction with IR. In recent years, numerous reports have suggested that mitochondrial dysregulation is associated with the pathogenesis of PCOS. Increased ROS, mutations/variants in mitochondrial DNA (mtDNA), and the altered expression of nuclear-related mitochondrial genes in insulin-resistant women with PCOS provide sufficient evidence for mitochondrial dysfunction as one of the factors contributing to PCOS pathogenesis. Despite the advancements in the field of interconnecting links between mitochondrial dysfunction, IR, and PCOS, various underlying mechanisms needs to be elucidated. Advancements in therapeutic interventions showed promising results in improving mitochondrial functions and IR in PCOS pathogenesis, including evolving mitochondrial transfer approaches that may improve in vitro fertilisation (IVF) outcomes in obese and insulin-resistant women with PCOS in future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Endocrinology, The Indian Council of Medical Research-National Institute for Research in Reproductive and Child Health (ICMR-NIRRCH), J.M. Street, Parel, Mumbai 400012, India.
ORCID-Profile: Samia Palat Tharayil, Pallavi Shukla
Förderung
- Indian Council of Medical Research (ICMR)
- ICMR-National Institute for Research in Reproductive and Child Health (NIRRCH)
Zitieren
APA
Tharayil, S. P., & Shukla, P. (2025). Connecting the Dots: Mitochondrial Dysfunction, PCOS, and Insulin Resistance—Insights and Therapeutic Advances. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136233
Vancouver
Tharayil SP, Shukla P. Connecting the Dots: Mitochondrial Dysfunction, PCOS, and Insulin Resistance—Insights and Therapeutic Advances. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136233
BibTeX
@article{Tharayil2025,
author = {Tharayil, Samia Palat and Shukla, Pallavi},
title = {Connecting the Dots: Mitochondrial Dysfunction, PCOS, and Insulin Resistance—Insights and Therapeutic Advances},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136233}
}
EUVIMED